CETP and age-related macular degeneration: Further genetic evidence from a total of 33,526 individuals predominantly of European ancestry from the International Age-related Macular Degeneration Genomics Consortium showed that increasing HDL-cholesterol (particularly via CETP inhibition) is a causal risk factor for AMD and that increasing HDL-cholesterol will increase AMD risk9.